Clinical Trials Directory

Trials / Unknown

UnknownNCT04635904

Imagery Rescripting and Imaginal Exposure for Social Anxiety: Mechanisms and Outcomes in an Analog Sample

Imagery Based Interventions for the Treatment of Anxiety Related Disorders: Mechanisms and Optimizing Outcomes

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
Hebrew University of Jerusalem · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

This study will recruit 100 participants who self-report high symptoms of social anxiety (Social phobia inventory \>30). Participants will be randomly assigned to receive either one analog intervention of Imagery Rescripting (IR) or Imaginal Exposure. We will test the efficacy and mechanisms behind each interventions.

Detailed description

After being informed about the study potential risks, all patients giving written informed consent will undergo screening to determine eligibility for study entry. They will be randomly assigned to two conditions (Imagery rescripting Vs. Imaginal exposure) at a 1:1 ratio. Participants will attend three \~1 hour online ZOOM sessions (pre-assessment and measurement, intervention, and post assessment and measurement). Assessors will be blind to the treatment condition.

Conditions

Interventions

TypeNameDescription
BEHAVIORALImaginal exposure one-sessionParticipants in this arm will be asked to decide alongside with the intervention provider (a clinical PhD student or M.A student under the supervision of the principal investigator) to imagine a script based on a future distressing anxiety provoking scenarios multiple times while honing in on the most negative aspects.
BEHAVIORALImagery rescriptinf one-sessionParticipants in this arm will be asked to decide alongside with the intervention provider (a clinical PhD student or M.A student under the supervision of the principal investigator) o imagine a script based on a future distressing anxiety provoking scenarios one time while honing in on the most negative aspects. Afterwards they will insert changes into the script that try to help them cope in the imagery.

Timeline

Start date
2021-04-19
Primary completion
2023-08-01
Completion
2023-08-01
First posted
2020-11-19
Last updated
2022-10-26

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT04635904. Inclusion in this directory is not an endorsement.